Cancer Research and Treatment

Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol

Jia-Ying Li, Shu-Nan Qi, Chen Hu, Xin Liu, Yong Yang, Tao Wu, Rong Zheng, Xiao-Li Feng, Xiao-Guang Ni, Feng-Yan Jin, Yu-Qin Song, Wei-Ping Liu, Sheng-Yu Zhou, Ye-Xiong Li

Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review

Mohammad Sadegh Fallahi, Nasibeh Zerangian, Atousa Ghorbani, Gisou Erabi, Melika Shirali, Elaheh Shabani, Foad Rommasi, Mahsa Mohammadi Najafabadi, Shima Karbasi, Samaneh Toutounchian, Ramin Ahangar-Sirous, Ava Motaghy, Mahsa Heidari, Niloofar Deravi

Current Cancer Therapy Reviews.2024; 20(1): 53. CrossRef

Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea

Ji Yun Lee, Ji Hyun Kwon, Joon Young Hur, Jun Ho Yi, Ji Hyun Lee, Hyungwoo Cho, Young Rok Do, Jae-Cheol Jo, Hye Jin Kang, Yougil Koh, Won Sik Lee, Sung Nam Lim, Sang Eun Yoon, Seok Jin Kim, Jeong-Ok Lee

Cancer Research and Treatment.2024; 56(2): 681. CrossRef

Counterproductive effects of anti-CD38 and checkpoint inhibitor for the treatment of NK/T cell lymphoma

Wendy W. L. Lee, Jing Quan Lim, Tiffany P. L. Tang, Daryl Tan, Ser Mei Koh, Kia Joo Puan, Liang Wei Wang, Jackwee Lim, Kim Peng Tan, Wee Joo Chng, Soon Thye Lim, Choon Kiat Ong, Olaf Rotzschke

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Mwanasha H. Merrill, Parastoo B. Dahi, Robert A. Redd, Mikaela M. McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F. Herrera, David C. Fisher, Ann S. LaCasce, Oreofe O. Odejide, Samuel Y. Ng, Caron A. Jacobson, Reid W. Merryman, Austin I. Kim, Yago L. Ni

The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis

Yanxia He, Yan Gao, Liqin Ping, Haixia He, Cheng Huang, Bing Bai, Xiaoxiao Wang, Zhiming Li, Qingqing Cai, Yuhua Huang, Xueyi Pan, Wenbin Zeng, Yanan Liu, Huiqiang Huang

Journal of Cancer Research and Clinical Oncology.2023; 149(5): 2017. CrossRef

Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment

Chunlan Zhang, Leiming Wang, Caigang Xu, Heng Xu, Yu Wu

The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies

Maria G. Desimio, Daniela A. Covino, Beatrice Rivalta, Caterina Cancrini, Margherita Doria

Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer

Jie Zhou, Guanming Chen, Jiuling Wang, Bo Zhou, Xuemin Sun, Jinsong Wang, Shu Tang, Xiangju Xing, Xiaofei Hu, Yang Zhao, Yu Peng, Wenjiong Shi, Tingting Zhao, Yuzhang Wu, Hanbing Zhong, Ni Hong, Zhihua Ruan, Yi Zhang, Wenfei Jin

Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies

Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative Review

Sarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau, Noémie Lang

First‐line immunotherapy with anti‐PD‐1 antibody for extranodal NK/T‐cell lymphoma: A retrospective study

Xiaoxiao Wang, Lei Wen, Jing Liao, Yanfen Feng, Yuhong Li, Zhaoming Zhou, Cheng Zhou, Huiqiang Huang

British Journal of Haematology.2023; 202(4): 812. CrossRef

Advances and challenges of immunotherapies in NK/T cell lymphomas

Adult's Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis: A case report

Yi Sun, Han Yao, Xiaofeng Yu, Yunzhao Chen, Chen Chai

Serious consequences of Epstein‐Barr virus infection: Hemophagocytic lymphohistocytosis

International Journal of Laboratory Hematology.2022; 44(1): 74. CrossRef

Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine

Ka-Hei (Murphy) Sun, Yin-Ting (Heylie) Wong, Ka-Man (Carmen) Cheung, Carmen (Michelle) Yuen, Yun-Tat (Ted) Chan, Wing-Yan (Jennifer) Lai, Chun (David) Chao, Wing-Sum (Katie) Fan, Yuen-Kiu (Karen) Chow, Man-Fai Law, Ho-Chi (Tommy) Tam

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers

Alison Felipe Bordini Biggi, Deilson Elgui de Oliveira

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma

EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk‐stratification, and management

Luis Malpica, Mario L. Marques‐Piubelli, Brady E. Beltran, Julio C. Chavez, Roberto N. Miranda, Jorge J. Castillo

American Journal of Hematology.2022; 97(7): 951. CrossRef

Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions

John C. Reneau, Polina Shindiapina, Zachary Braunstein, Youssef Youssef, Miguel Ruiz, Saira Farid, Walter Hanel, Jonathan E. Brammer

Journal of Clinical Medicine.2022; 11(10): 2699. CrossRef

Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders

Susan Swee-Shan Hue, Siok-Bian Ng, Shi Wang, Soo-Yong Tan

Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trials

Yang Xu, Ping Li, Yang Liu, Dijia Xin, Wen Lei, Aibin Liang, Weidong Han, Wenbin Qian

Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression

N Nora Bennani, Hyo Jin Kim, Levi D Pederson, Pamela J Atherton, Ivana N Micallef, Gita Thanarajasingam, Grzegorz S Nowakowski, Thomas Witzig, Andrew L Feldman, Stephen M Ansell

Journal for ImmunoTherapy of Cancer.2022; 10(6): e004984. CrossRef

Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma

Felix Marsh-Wakefield, Angela L Ferguson, Ken Liu, Cositha Santhakumar, Geoffrey McCaughan, Umaimainthan Palendira

Therapeutic Advances in Medical Oncology.2022; 14: 175883592211132. CrossRef

Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management

Eric Tse, Christopher P. Fox, Alexander Glover, Sang Eun Yoon, Won Seog Kim, Yok-Lam Kwong

Seminars in Hematology.2022; 59(4): 198. CrossRef

Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma

Seok Jin Kim, Kyung Ju Ryu, Bon Park, Sang Eun Yoon, Junhun Cho, Yoon Park, Won Seog Kim

Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma

Guang-Liang Chen, Zu-Guang Xia, Jia Jin, Bao-Hua Yu, Junning Cao, Amir Radfar

Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review

Lee S. Nguyen, Lisa Raia, Bénédicte Lebrun-Vignes, Joe-Elie Salem

Pulmonary Lymphoepithelioma-Like Carcinoma Treated with Immunotherapy or Chemotherapy: A Single Institute Experience

Yang Fu, Yue Zheng, Pei-Pei Wang, Yue-Yun Chen, Zhen-Yu Ding

OncoTargets and Therapy.2021; Volume 14: 1073. CrossRef

Y. Dieudonne, M. Martin, A.-S. Korganow, D. Boutboul, A. Guffroy

La Revue de Médecine Interne.2021; 42(12): 832. CrossRef

PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma

Joshua W. D. Tobin, Karolina Bednarska, Ashlea Campbell, Colm Keane

The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

Won Seog Kim, Yasuhiro Oki, Seok Jin Kim, Sang Eun Yoon, Kirit M. Ardeshna, Yi Lin, Jia Ruan, Pierluigi Porcu, Jonathan E. Brammer, Eric D. Jacobsen, Dok Hyun Yoon, Cheolwon Suh, Felipe Suarez, John Radford, Lihua E. Budde, Jin Seok Kim, Emmanuel Bachy, H

Annals of Hematology.2021; 100(10): 2529. CrossRef

The role of Epstein–Barr virus-encoded latent membrane proteins in host immune escape

EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)

Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, Maurizio Zizzo, Giovanni Martino, Cecilia Caprera, Valentina Fragliasso, Alessandra Soriano, Luca Valle, Stefano Ricci, Alberto Cavazza, Francesco Merli, Stefano A. Pileri, Stefano Ascani

Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report

Fatemeh Adabifirouzjaei, Bharam Khazai, Ghazaleh Azami, Ghazaleh Shoja-e-Razavi

Journal of Medical Case Reports.2021;[Epub] CrossRef

Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas

Miriam Verdu-Bou, Gustavo Tapia, Agueda Hernandez-Rodriguez, Jose-Tomas Navarro

Regulation of the Immune Checkpoint Indoleamine 2,3-Dioxygenase Expression by Epstein–Barr Virus

Leila Sawada, Antonio Carlos Rosário Vallinoto, Igor Brasil-Costa

Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

Alejandro Olivares-Hernández, Luis Figuero-Pérez, José Pablo Miramontes-González, Álvaro López-Gutiérrez, Rogelio González-Sarmiento, Juan Jesús Cruz-Hernández, Emilio Fonseca-Sánchez

EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk‐stratification and management

Brady E. Beltran, Denisse Castro, Sally Paredes, Roberto N. Miranda, Jorge J. Castillo

American Journal of Hematology.2020; 95(4): 435. CrossRef

Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression

Junhun Cho, Seok Jin Kim, Woong-Yang Park, Jinho Kim, Jeongmin Woo, Gahyun Kim, Sang Eun Yoon, Young Hyeh Ko, Won Seog Kim

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Matthew J. Frigault, Philippe Armand, Robert A. Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Alex F. Herrera, Parastoo Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreife O. Odejide, Arnold S. Freedman, Austin I. Kim, Jenni

CDC27 Promotes Tumor Progression and Affects PD-L1 Expression in T-Cell Lymphoblastic Lymphoma

Yue Song, Wei Song, Zhaoming Li, Wenting Song, Yibo Wen, Jiwei Li, Qingxin Xia, Mingzhi Zhang

Stage IV natural killer/T-cell lymphoma with chronic active Epstein–Barr virus, treated with pembrolizumab and TCRαβ-depleted haploidentical hematopoietic stem cell transplantation

Yeong Eun Kim, Hyery Kim, Juhee Shin, So Yoon Min, Sung Han Kang, Jin Kyung Suh, Kyung-Nam Koh, Ho Joon Im

Virus-Specific T Cells for the Treatment of Malignancies—Then, Now, and the Future

Current Stem Cell Reports.2020; 6(2): 17. CrossRef

The roles of programmed death ligand 1 in virus-associated cancers

Morvarid Golrokh Mofrad, Donya Taghizadeh Maleki, Ebrahim Faghihloo

Infection, Genetics and Evolution.2020; 84: 104368. CrossRef

Ayumi Kuzume, SungGi Chi, Nobuhiko Yamauchi, Yosuke Minami

International Journal of Molecular Sciences.2020; 21(15): 5456. CrossRef

Multiplex immunohistochemistry in lymphoma pathology: a research tool for study of the immune microenvironment

Matthew Pugh, Ayse U. Akarka, Kelly Hunter, Stefan Dojcinov, Teresa Marafioti

Diagnostic Histopathology.2020; 26(9): 407. CrossRef

Targeting immune checkpoints in hematological malignancies

Journal of Hematology & Oncology.2020;[Epub] CrossRef

Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals

Polina Shindiapina, Elshafa H. Ahmed, Anna Mozhenkova, Tamrat Abebe, Robert A. Baiocchi

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches

Ji-Yoon Noh, Huiyun Seo, Jungwoon Lee, Haiyoung Jung

International Journal of Molecular Sciences.2020; 21(21): 8000. CrossRef

EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas

Danielle L.V. Maracaja, Vidya Puthenpura, Salley G. Pels, Dennis P. O’Malley, Jeffrey L. Sklar, Karin E. Finberg, Mina L. Xu

Applied Immunohistochemistry & Molecular Morphology.2020; 28(10): 725. CrossRef

Current Immunotherapy Approaches in Non-Hodgkin Lymphomas

Robert Pytlik, Kamila Polgarova, Jana Karolova, Pavel Klener

Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review

Zheng Yan, Shuna Yao, Yanyan Liu, Jianbo Zhang, Peng Li, Haiying Wang, Junfeng Chu, Shuang Zhao, Zhihua Yao

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study

Seok Jin Kim, Jing Quan Lim, Yurike Laurensia, Junhun Cho, Sang Eun Yoon, Ji Young Lee, Kyung Ju Ryu, Young Hyeh Ko, Youngil Koh, Duck Cho, Soon Thye Lim, Marie Beck Enemark, Francesco D’Amore, Mette Bjerre, Choon Kiat Ong, Won Seog Kim

Immune checkpoint inhibitors in the treatment of virus-associated cancers

Peipei Gao, Cordelle Lazare, Canhui Cao, Yifan Meng, Ping Wu, Wenhua Zhi, Shitong Lin, Juncheng Wei, Xiaoyuan Huang, Ling Xi, Gang Chen, Junbo Hu, Ding Ma, Peng Wu

Journal of Hematology & Oncology.2019;[Epub] CrossRef